Allurion Technologies Inc. (ALUR)
Automate Your Wheel Strategy on ALUR
With Tiblio's Option Bot, you can configure your own wheel strategy including ALUR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ALUR
- Rev/Share 5.9231
- Book/Share -14.6049
- PB -0.1849
- Debt/Equity -0.4725
- CurrentRatio 2.0863
- ROIC -2.0153
- MktCap 20135952.0
- FreeCF/Share -9.1325
- PFCF -0.4614
- PE -0.5298
- Debt/Assets 0.8584
- DivYield 0
- ROE 0.3453
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | ALUR | TD Cowen | -- | Buy | -- | $2 | Oct. 2, 2024 |
| Initiation | ALUR | ROTH MKM | -- | Buy | -- | $2 | Sept. 6, 2024 |
News
4 Medical Product Stocks to Watch From a Challenging Industry
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Negative
The U.S. government's tariff imposition, especially on China, is likely to keep supply chains under pressure for the Zacks Medical Products industry. PODD, MGNX, CLRB and ALUR reflect the favorable fundamentals.
Read More
Allurion Technologies Inc. (ALUR) Q1 2025 Earnings Call Transcript
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Neutral
Allurion Technologies Inc. (NYSE:ALUR ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Tara Brady - Interim CFO Shantanu Gaur - Founder and CEO Conference Call Participants Jason Wittes - ROTH Capital Partners Josh Jennings - TD Cowen Keay Nakae - Chardan Capital Mike Toomey - Jefferies Operator Hello, everyone, and welcome to Allurion First Quarter Earnings Call. All lines have been placed on mute to prevent any background noise.
Read More
Allurion Technologies, Inc. (ALUR) Q1 Earnings Beat Estimates
Published: May 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Allurion Technologies, Inc. (ALUR) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of a loss of $1.53 per share. This compares to earnings of $2.75 per share a year ago.
Read More
4 Medical Product Stocks to Buy From a Challenging Industry
Published: April 17, 2025 by: Zacks Investment Research
Sentiment: Positive
The U.S. government's tariff imposition, especially on China, is likely to keep supply chains under pressure for the Zacks Medical Products industry. PODD, MGNX, CLRB and ALUR are likely to gain from the favorable factors.
Read More
Allurion Technologies Inc. (ALUR) Q4 2024 Earnings Call Transcript
Published: March 26, 2025 by: Seeking Alpha
Sentiment: Neutral
Allurion Technologies Inc. (NYSE:ALUR ) Q4 2024 Earnings Conference Call March 26, 2025 8:30 AM ET Company Participants Mike Cavanaugh - Investor Relations Shantanu Gaur - Founder and Chief Executive Officer Conference Call Participants Matthew Taylor - Jefferies Josh Jennings - TD Cowen Jason Wittes - ROTH Capital Partners Keay Nakae - Chardan Capital Operator Hello, everyone, and welcome to Allurion Fourth Quarter Earnings Call. Please note that this call is being recorded.
Read More
How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67%
Published: February 10, 2025 by: Zacks Investment Research
Sentiment: Positive
The mean of analysts' price targets for Allurion Technologies, Inc. (ALUR) points to a 374.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read More
About Allurion Technologies Inc. (ALUR)
- IPO Date 2021-03-29
- Website https://www.allurion.com
- Industry Medical - Devices
- CEO Dr. Shantanu K. Gaur M.D.
- Employees 134